FDA advisers on May 9 will meet to discuss HRA Pharma’s application for the first-ever over-the-counter birth control pill in the United States, the agency announced Tuesday (March 28) , five months after postponing discussions on the pill. If HRA’s oral drug, Opill, is approved, it will be a significant step toward increasing access to contraception in the wake of the Supreme Court’s landmark reversal of Roe v. Wade , women’s health experts say. Making the pill available OTC would...